Experts

Experts speaking @ CGT-SUMMIT 2024

Alan M. Lambowitz
Alan M. Lambowitz

Professor
The University of Texas at Austin, TX

Rudolf Jaenisch
Rudolf Jaenisch

Professor
MIT, MA

Ula V. Jurkunas
Ula V. Jurkunas
Associate Professor of Ophthalmology
Harvard Medical School, MA
Jerome Chal
Jerome Chal

SVP, Head of CMC
Myeloid Therapeutics, MA

Luis Pereira de Almeida
Luis Pereira de Almeida

President
CNC UC, Portugal

Lynne Frick
Lynne Frick

President & CEO
Cell X Technologies, OH

Rachel Salzman
Rachel Salzman

CEO
Armatus Bio, OH

Joseph Pekny
Joseph Pekny

Co-Founder/CEO
Advanced Process Combinatorics Inc., IN

Irene Rombel
Irene Rombel

CEO and Co-founder
BioCurie, DE

Michael Mehler
Michael Mehler

Director, Cell Therapy Supply Chain & Operations
Takeda Pharmaceuticals, MA

David McNally
David McNally

Head of Viral Vector Technology
MassBiologics, MA

Chang Li
Chang Li

Assistant Professor
University of Washington, WA

Moritz von Stosch
Moritz von Stosch

Chief Innovation Officer
Datahow, Switzerland

Jason Criscione
Jason Criscione

Chief Scientific Officer
Enquyst Technologies, Inc., MA

Kira Gillett
Kira Gillett

Program Manager, Translational Science
FNIH, MD

Hiroshi Sugimoto
Hiroshi Sugimoto

Associate Director
Takeda Development Center Americas Inc., MA

Kimberley Buytaert-Hoefen
Kimberley Buytaert-Hoefen

Executive Director & Global Head of Regulatory Affairs
QPS LLC, DE

Amir Hefni
Amir Hefni

Chief Executive Officer
Resolution Therapeutics, UK

Xingxing Zang
Xingxing Zang

Louis Goldstein Swan Chair in Cancer Research
Albert Einstein College of Medicine, NY

Yuechao Zhao
Yuechao Zhao

Director, R&D
Celularity Inc., NJ

Nick Lai
Nick Lai

Senior Scientist
Regeneron Pharmaceuticals, NY

Larry Forman
Larry Forman

Founder and CEO
CHO Plus, Inc., CA

Asaf Hellman
Asaf Hellman

Professor
The Hebrew University, Israel

Dr. Anand Srivastava
Anand Srivastava

Chairman and Cofounder
Global Institute of Stem Cell Therapy and Research (GIOSTAR), CA

Susan M. Faust
Susan M. Faust

Patent Specialist
Hogan Lovells US LLP, DC

Ruby Tsai
Ruby Tsai

CEO & Co-Founder
Applied StemCell, CA

Liping Yu
Liping Yu

VP, Application
Applied Cells, CA

John Lu
John Lu

President and CEO
HebeCell, MA

Alicia D. Henn
Alicia D. Henn

CSO
BioSpherix, Ltd., NY

Zeynep Guillemin
Zeynep Guillemin

Senior Scientist
Voyager Therapeutics, MA

Parameswaran Hari
Parameswaran Hari

Chief Development Officer
Obsidian Therapeutics, MA

Tetsuya Yamagata
Tetsuya Yamagata

Chief Scientific Officer
Modalis Therapeutics Inc., MA

Jesse Kay
Jesse Kay

Business Development Manager
PROGEN Biotech Inc., AR

Demet (Dee) Sag
Demet (Dee) Sag

Founder
Genome2Life, MA

Greg Kunst
Greg Kunst

CEO
Aurion Biotech, WA

Jaspreet Khurana
Jaspreet Khurana

Senior Director, mRNA Programming
Strand Therapeutics, MA

Michael Krohn
Michael Krohn

Executive Vice President
Leading Akribion Genomics, Germany

Erin Kimbrel
Erin Kimbrel

President
Astellas Institute for Regenerative Medicine, MA

Victor Hernandez
Victor Hernandez

Chief Scientific Officer
Axovia Therapeutics Ltd, UK

Sally Gu
Sally Gu

Senior Associate
Hogan Lovells US LLP, DC

Huiren Zhao
Huiren Zhao

Principle Scientist
Amgen, CA

Elisa Cuevas
Elisa Cuevas

Head of NPD
4basebio Discovery Ltd, UK

Nidhi Kotecha
Nidhi Kotecha

Program Director
Regulatory Affairs, Gates Institute, CO

For regular updates bookmark Global Cell & Gene Therapy Summit website